Teradyne, Inc. (TER)
Quantitative Summary
DeterministicTER trades at 69.4x earnings, roughly in line with its sector average of 65.0x. Financial health is average: Piotroski 5/9, Altman Z 26.7. DCF fair value of $44 implies 88% downside based on model assumptions. Beneish M-Score of -2.14 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedTeradyne, Inc. exhibits a robust fundamental profile characterized by an ROIC-WACC spread of 17%, indicating efficient capital allocation relative to its cost of equity. The DuPont decomposition reveals that the 19.8% return on equity is primarily driven by exceptional net margins at 17.4% and strong gross margins of 58.2%, rather than leverage or asset turnover, which sit at moderate levels of 1.50x and 0.76x respectively. Financial integrity metrics further support this quality assessment, with a high Altman Z-Score of 21.3 suggesting low bankruptcy risk and a negative Beneish M-Score of -2.14 signaling minimal earnings manipulation concerns; however, the Piotroski F-Score of 5/9 indicates moderate financial strength without recent significant deterioration or improvement in balance sheet dynamics.
Valuation metrics present a stark divergence between current market pricing and intrinsic value models. The stock trades at a P/E ratio of 89.2x, which is more than double the sector average of 42.2x, implying that investors are anticipating sustained high-growth trajectories far exceeding historical norms. This premium valuation aligns with an implied free cash flow growth rate of 10-year annualized 42.6%, yet a discounted cash flow analysis suggests a fair value of $25, resulting in a calculated downside of -91.7% from current levels. Such a wide gap between the multiple expansion required to justify current prices and the DCF-derived floor highlights significant expectation risk embedded within the share price.
Risk factor data introduces conflicting signals regarding future performance sustainability despite strong alpha generation. While the Fama-French annualized alpha of 104.18% demonstrates substantial outperformance relative to standard factors, the Profitability Factor score of -0.839 flags a weakness in profitability adjustments that may contradict the high margin narrative over longer horizons. Additionally, recent insider activity shows $748,570 net selling over ninety days, which often precedes or accompanies periods of elevated valuation concern. The Value Factor tilt at 0.283 suggests the stock currently lacks value characteristics despite its profitability issues, creating a complex risk-reward profile where strong historical alpha coexists with deteriorating relative profitability and insider distribution.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 13% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 8% | 10% | 12% |
|---|---|---|---|
| 2% | $53 | $40 | $33 |
| 3% | $61 | $44 | $35 |
| 4% | $74 | $50 | $38 |
Center = base case. Green = >10% upside, Red = >10% downside vs $392.62.
Pre-computed DCF: WACC=10.0%, terminal growth 3%. Fair value $44 (-88.0%). Not investment advice.
Valuation Context
Currently trading 68% above its 5-year average P/E of 63.3x.
Price Chart with Moving Averages
Technical Setup
AI GeneratedThe current price of TER is above both its 50-day and 200-day moving averages, indicating a strong upward trend in the short to medium term. With an RSI of 47.8, the stock appears to be at midpoint levels regarding overbought or oversold conditions, suggesting it may still have room for continued price appreciation before reaching potentially overextended territory.
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Dividend History
| Date | Amount | Change |
|---|---|---|
| 2026-05-21 | $0.1300 | 0.0% |
| 2026-02-13 | $0.1300 | +8.3% |
| 2025-11-24 | $0.1200 | 0.0% |
| 2025-09-05 | $0.1200 | 0.0% |
| 2025-05-22 | $0.1200 | 0.0% |
| 2025-02-14 | $0.1200 | 0.0% |
| 2024-11-25 | $0.1200 | 0.0% |
| 2024-09-05 | $0.1200 | 0.0% |
| 2024-05-21 | $0.1200 | 0.0% |
| 2024-02-15 | $0.1200 | +9.1% |
| 2023-11-24 | $0.1100 | 0.0% |
| 2023-08-31 | $0.1100 | 0.0% |
Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fama-French 5-Factor Exposure
Academic factor model decomposition — what's really driving this stock's returns.
Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like ARKQ or ARKX, the fund manager is mechanically forced to buy or sell TER shares regardless of Teradyne, Inc.'s individual fundamentals. We estimate $8.6B of passive capital is structurally linked to TER through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in Teradyne, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If Teradyne, Inc. (TER) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies TESLA INC (TSLA) as the most exposed collateral stock, sharing 2 ETFs with TER. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 34 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
TER Ownership Dynamics
Passive funds hold 1 in every 5 TER shares, reducing daily market volatility.
Teradyne, Inc. (TER) exerts notable gravity on the passive index market, currently representing 7.6% of the ARKQ (ARKQ) and 7.2% of the ARKX (ARKX). Across 36 tracked ETFs, approximately 33M shares (20.9% of float) are held by passive funds and rarely trade on the open market. This high passive lock-up reduces the effective active float, which can amplify daily price volatility and momentum signals.
ETFs with Highest TER Exposure
Float lock-up computed from 36 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
TER Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for Teradyne, Inc. over the past year sits near $86.22 (14% of 252-day volume). The current price of $392.62 trades 355.3% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (14% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
TER Capital Efficiency
How efficiently does Teradyne, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
Teradyne, Inc. converts 57% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 29,947 | $358.45 | $10.7M |
| 2026-05-11 | 100 | $359.77 | $35,977 |
| 2026-05-05 | 1 | $337.44 | $337.44 |
| 2026-04-30 | 11 | $306.33 | $3,369.63 |
| 2026-04-23 | 1 | $385.18 | $385.18 |
| 2026-04-21 | 399 | $375.21 | $149,708.79 |
| 2026-04-20 | 3,200 | $380.38 | $1.2M |
| 2026-04-16 | 1 | $364.96 | $364.96 |
| 2026-04-13 | 1,123 | $367.99 | $413,252.77 |
| 2026-04-10 | 20,543 | $364.21 | $7.5M |
| 2026-04-09 | 2 | $358.29 | $716.58 |
| 2026-04-07 | 10 | $315.43 | $3,154.3 |
| 2026-04-06 | 38,379 | $309.61 | $11.9M |
| 2026-04-02 | 16 | $312.20 | $4,995.2 |
| 2026-04-01 | 743 | $296.46 | $220,269.78 |
| 2026-03-30 | 3 | $295.61 | $886.83 |
| 2026-03-25 | 590 | $320.14 | $188,882.6 |
| 2026-03-24 | 116,826 | $303.92 | $35.5M |
| 2026-03-23 | 300 | $290.83 | $87,249 |
| 2026-03-17 | 56,845 | $298.27 | $17.0M |
| 2026-03-05 | 3 | $305.20 | $915.6 |
| 2026-03-02 | 1,194 | $320.03 | $382,115.82 |
| 2026-02-25 | 3 | $329.09 | $987.27 |
| 2026-02-23 | 2,334 | $324.85 | $758,199.9 |
| 2026-02-17 | 53,382 | $314.66 | $16.8M |
| 2026-02-13 | 10 | $311.03 | $3,110.3 |
| 2026-02-11 | 6 | $304.89 | $1,829.34 |
| 2026-02-10 | 179 | $310.01 | $55,491.79 |
| 2026-02-09 | 480 | $300.11 | $144,052.8 |
| 2026-02-04 | 30 | $282.98 | $8,489.4 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
SEC Comment Letters
SEC correspondence with the company regarding their filings. Comment letters often flag disclosure deficiencies, accounting concerns, or material omissions.
Source: SEC EDGAR correspondence. Comment letters are public records of SEC staff review of company filings.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| CAT | 0.696 | 0.780 | Moderate |
| LRCX | 0.645 | 0.704 | Moderate |
| AMAT | 0.644 | 0.710 | Moderate |
| MPWR | 0.608 | 0.686 | Moderate |
| CMI | 0.596 | 0.644 | Moderate |
| KLAC | 0.596 | 0.645 | Moderate |
| WDC | 0.585 | 0.681 | Moderate |
| ASML | 0.577 | 0.640 | Moderate |
| USN070592100 | 0.577 | 0.640 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare TER to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.